ATE270280T1 - Substituierte dipeptide zur förderung der sekretion von wachstumshormon - Google Patents
Substituierte dipeptide zur förderung der sekretion von wachstumshormonInfo
- Publication number
- ATE270280T1 ATE270280T1 AT01979233T AT01979233T ATE270280T1 AT E270280 T1 ATE270280 T1 AT E270280T1 AT 01979233 T AT01979233 T AT 01979233T AT 01979233 T AT01979233 T AT 01979233T AT E270280 T1 ATE270280 T1 AT E270280T1
- Authority
- AT
- Austria
- Prior art keywords
- growth hormone
- secretion
- promote
- compounds
- novel
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D275/00—Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings
- C07D275/04—Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings condensed with carbocyclic rings or ring systems
- C07D275/06—Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings condensed with carbocyclic rings or ring systems with hetero atoms directly attached to the ring sulfur atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/06—Dipeptides
- C07K5/06191—Dipeptides containing heteroatoms different from O, S, or N
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/06—Drugs for disorders of the endocrine system of the anterior pituitary hormones, e.g. TSH, ACTH, FSH, LH, PRL, GH
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/06—Dipeptides
- C07K5/06008—Dipeptides with the first amino acid being neutral
- C07K5/06017—Dipeptides with the first amino acid being neutral and aliphatic
- C07K5/06026—Dipeptides with the first amino acid being neutral and aliphatic the side chain containing 0 or 1 carbon atom, i.e. Gly or Ala
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biochemistry (AREA)
- Diabetes (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Endocrinology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Peptides Or Proteins (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US24045600P | 2000-10-13 | 2000-10-13 | |
PCT/US2001/027756 WO2002032888A1 (en) | 2000-10-13 | 2001-10-09 | Substituted dipeptides as growth hormone secretagogues |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE270280T1 true ATE270280T1 (de) | 2004-07-15 |
Family
ID=22906598
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT01979233T ATE270280T1 (de) | 2000-10-13 | 2001-10-09 | Substituierte dipeptide zur förderung der sekretion von wachstumshormon |
Country Status (27)
Country | Link |
---|---|
EP (1) | EP1326851B1 (de) |
JP (1) | JP2004511552A (de) |
KR (1) | KR20030042014A (de) |
CN (1) | CN1469871A (de) |
AT (1) | ATE270280T1 (de) |
AU (2) | AU2002211219B2 (de) |
BR (1) | BR0114630A (de) |
CA (1) | CA2419388A1 (de) |
CZ (1) | CZ20031029A3 (de) |
DE (1) | DE60104141T2 (de) |
DZ (1) | DZ3482A1 (de) |
EA (1) | EA006102B1 (de) |
EC (1) | ECSP034551A (de) |
ES (1) | ES2223926T3 (de) |
HK (1) | HK1058194A1 (de) |
HR (1) | HRP20030288B1 (de) |
HU (1) | HUP0301351A3 (de) |
IL (1) | IL154809A0 (de) |
MX (1) | MXPA03003217A (de) |
NO (1) | NO20031687L (de) |
NZ (1) | NZ524232A (de) |
PL (1) | PL361675A1 (de) |
PT (1) | PT1326851E (de) |
SK (1) | SK4182003A3 (de) |
TR (1) | TR200402046T4 (de) |
WO (1) | WO2002032888A1 (de) |
ZA (1) | ZA200301720B (de) |
Families Citing this family (47)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ES2271557T3 (es) * | 2002-04-09 | 2007-04-16 | Eli Lilly And Company | Secretagogos dipeptidicos de la hormona del crecimiento. |
US7105526B2 (en) | 2002-06-28 | 2006-09-12 | Banyu Pharmaceuticals Co., Ltd. | Benzimidazole derivatives |
US7772188B2 (en) | 2003-01-28 | 2010-08-10 | Ironwood Pharmaceuticals, Inc. | Methods and compositions for the treatment of gastrointestinal disorders |
WO2005028438A1 (ja) | 2003-09-22 | 2005-03-31 | Banyu Pharmaceutical Co., Ltd. | 新規ピペリジン誘導体 |
EP2305352A1 (de) | 2004-04-02 | 2011-04-06 | Merck Sharp & Dohme Corp. | 5-alpha-Reduktaseinhibitoren zur Behandlung von Stoffwechsel- und anthropometrischen Störungen |
ES2574014T3 (es) | 2005-05-30 | 2016-06-14 | Msd K.K. | Derivado de piperidina novedoso |
EP1916239A4 (de) | 2005-08-10 | 2009-10-21 | Banyu Pharma Co Ltd | Pyridolverbindung |
EP1921065B1 (de) | 2005-08-24 | 2010-10-20 | Banyu Pharmaceutical Co., Ltd. | Phenylpyridonderivat |
WO2007029847A1 (ja) | 2005-09-07 | 2007-03-15 | Banyu Pharmaceutical Co., Ltd. | 二環性芳香族置換ピリドン誘導体 |
EP1940842B1 (de) | 2005-09-29 | 2012-05-30 | Merck Sharp & Dohme Corp. | Acylierte spiropiperidinderivate als modulatoren des melanocortin-4-rezeptors |
BRPI0617621A2 (pt) | 2005-10-21 | 2011-08-02 | Novartis Ag | combinação de compostos orgánicos |
AU2006307046A1 (en) | 2005-10-27 | 2007-05-03 | Msd K.K. | Novel benzoxathiin derivative |
MY146564A (en) | 2005-11-10 | 2012-08-30 | Msd Kk | Aza-substituted spiro derivatives |
EP2698157B1 (de) | 2006-09-22 | 2015-05-20 | Merck Sharp & Dohme Corp. | Verfahren zur Behandlung von Fettsäure-Synthese-Hemmern |
WO2008038692A1 (fr) | 2006-09-28 | 2008-04-03 | Banyu Pharmaceutical Co., Ltd. | dÉrivÉ de diarylcÉtimine |
AU2008233662B2 (en) | 2007-04-02 | 2012-08-23 | Msd K.K. | Indoledione derivative |
US7879802B2 (en) | 2007-06-04 | 2011-02-01 | Synergy Pharmaceuticals Inc. | Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders |
US8969514B2 (en) | 2007-06-04 | 2015-03-03 | Synergy Pharmaceuticals, Inc. | Agonists of guanylate cyclase useful for the treatment of hypercholesterolemia, atherosclerosis, coronary heart disease, gallstone, obesity and other cardiovascular diseases |
CA2714617A1 (en) | 2008-03-06 | 2009-09-11 | Banyu Pharmaceutical Co., Ltd. | Alkylaminopyridine derivative |
US20110015198A1 (en) | 2008-03-28 | 2011-01-20 | Banyu Pharmaceutical Co., Inc. | Diarylmethylamide derivative having melanin-concentrating hormone receptor antagonism |
EP3239170B1 (de) | 2008-06-04 | 2019-03-20 | Synergy Pharmaceuticals Inc. | Für die behandlung von gastrointestinalen erkrankungen, entzündungen, krebs und anderen erkrankungen geeignete agonisten von guanylatcyclase |
EP2301936A1 (de) | 2008-06-19 | 2011-03-30 | Banyu Pharmaceutical Co., Ltd. | Spirodiamin-diarylketoximid-derivat |
EP3241839B1 (de) | 2008-07-16 | 2019-09-04 | Bausch Health Ireland Limited | Zur behandlung von erkrankungen des magen-darm-trakts, entzündlichen erkrankungen, krebs und anderen erkrankungen geeignete agonisten von guanylatcyclase |
EP2319841A1 (de) | 2008-07-30 | 2011-05-11 | Msd K.K. | (5-gliedriges)-(5-gliedriges) oder (5-gliedriges)-(6-gliedriges) kondensiertes ringcycloalkylaminderivat |
CA2741125A1 (en) | 2008-10-22 | 2010-04-29 | Merck Sharp & Dohme Corp. | Novel cyclic benzimidazole derivatives useful anti-diabetic agents |
CA2741644C (en) | 2008-10-30 | 2013-05-07 | Merck Sharp & Dohme Corp. | Isonicotinamide orexin receptor antagonists |
WO2010051206A1 (en) | 2008-10-31 | 2010-05-06 | Merck Sharp & Dohme Corp. | Novel cyclic benzimidazole derivatives useful anti-diabetic agents |
US8314250B2 (en) * | 2009-11-24 | 2012-11-20 | Hoffmann-La Roche Inc. | Sultam derivatives |
US8895596B2 (en) | 2010-02-25 | 2014-11-25 | Merck Sharp & Dohme Corp | Cyclic benzimidazole derivatives useful as anti-diabetic agents |
US9616097B2 (en) | 2010-09-15 | 2017-04-11 | Synergy Pharmaceuticals, Inc. | Formulations of guanylate cyclase C agonists and methods of use |
EP2677869B1 (de) | 2011-02-25 | 2017-11-08 | Merck Sharp & Dohme Corp. | Neue cyclische azabenzimidazolderivate als antidiabetika |
AR088352A1 (es) | 2011-10-19 | 2014-05-28 | Merck Sharp & Dohme | Antagonistas del receptor de 2-piridiloxi-4-nitrilo orexina |
AU2013296470B2 (en) | 2012-08-02 | 2016-03-17 | Merck Sharp & Dohme Corp. | Antidiabetic tricyclic compounds |
AU2014219020A1 (en) | 2013-02-22 | 2015-07-23 | Merck Sharp & Dohme Corp. | Antidiabetic bicyclic compounds |
WO2014139388A1 (en) | 2013-03-14 | 2014-09-18 | Merck Sharp & Dohme Corp. | Novel indole derivatives useful as anti-diabetic agents |
US9708367B2 (en) | 2013-03-15 | 2017-07-18 | Synergy Pharmaceuticals, Inc. | Agonists of guanylate cyclase and their uses |
CA2905435A1 (en) | 2013-03-15 | 2014-09-25 | Synergy Pharmaceuticals Inc. | Compositions useful for the treatment of gastrointestinal disorders |
JP6606491B2 (ja) | 2013-06-05 | 2019-11-13 | シナジー ファーマシューティカルズ インコーポレイテッド | グアニル酸シクラーゼcの超高純度アゴニスト、その作成および使用方法 |
WO2015051496A1 (en) | 2013-10-08 | 2015-04-16 | Merck Sharp & Dohme Corp. | Antidiabetic tricyclic compounds |
JP6769963B2 (ja) | 2014-08-29 | 2020-10-14 | ティエエッセ ファルマ ソチエタ レスポンサビリタ リミタータ | α−アミノ−β−カルボキシムコン酸セミアルデヒド脱炭酸酵素の阻害剤 |
AU2017342083A1 (en) | 2016-10-14 | 2019-04-11 | Tes Pharma S.R.L. | Inhibitors of alpha-amino-beta-carboxymuconic acid semialdehyde decarboxylase |
EP3551176A4 (de) | 2016-12-06 | 2020-06-24 | Merck Sharp & Dohme Corp. | Antidiabetische heterocyclische verbindungen |
EP3558298A4 (de) | 2016-12-20 | 2020-08-05 | Merck Sharp & Dohme Corp. | Antidiabetische spirochromanverbindungen |
KR20210111248A (ko) | 2018-11-20 | 2021-09-10 | 테스 파마 에스.알.엘. | α-아미노-β-카르복시뮤콘산 세미알데하이드 데카르복실라제의 저해제 |
WO2020167706A1 (en) | 2019-02-13 | 2020-08-20 | Merck Sharp & Dohme Corp. | 5-alkyl pyrrolidine orexin receptor agonists |
WO2021026047A1 (en) | 2019-08-08 | 2021-02-11 | Merck Sharp & Dohme Corp. | Heteroaryl pyrrolidine and piperidine orexin receptor agonists |
CR20230089A (es) | 2020-08-18 | 2023-04-11 | Merck Sharp & Dohme Llc | Agonistas de bicicloheptano pirrolidina de los receptores de orexina |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU4993497A (en) * | 1996-10-25 | 1998-05-22 | Merck & Co., Inc. | Convergent process for the preparation of a growth hormone secretagogue |
UA53716C2 (uk) * | 1997-06-25 | 2003-02-17 | Пфайзер Продактс Інк. | Тартратна сіль заміщеного дипептиду, спосіб її одержання, проміжні сполуки та спосіб їх одержання, фармацевтична композиція (варіанти), спосіб підвищення рівнів ендогенного гормону росту та спосіб лікування або профілактики захворювань (варіанти) |
-
2001
- 2001-10-09 CN CNA018172822A patent/CN1469871A/zh active Pending
- 2001-10-09 SK SK418-2003A patent/SK4182003A3/sk unknown
- 2001-10-09 NZ NZ524232A patent/NZ524232A/en unknown
- 2001-10-09 DE DE60104141T patent/DE60104141T2/de not_active Expired - Lifetime
- 2001-10-09 WO PCT/US2001/027756 patent/WO2002032888A1/en active IP Right Grant
- 2001-10-09 PT PT01979233T patent/PT1326851E/pt unknown
- 2001-10-09 CA CA002419388A patent/CA2419388A1/en not_active Abandoned
- 2001-10-09 IL IL15480901A patent/IL154809A0/xx unknown
- 2001-10-09 EA EA200300462A patent/EA006102B1/ru not_active IP Right Cessation
- 2001-10-09 CZ CZ20031029A patent/CZ20031029A3/cs unknown
- 2001-10-09 ES ES01979233T patent/ES2223926T3/es not_active Expired - Lifetime
- 2001-10-09 BR BR0114630-0A patent/BR0114630A/pt not_active IP Right Cessation
- 2001-10-09 JP JP2002536270A patent/JP2004511552A/ja active Pending
- 2001-10-09 EP EP01979233A patent/EP1326851B1/de not_active Expired - Lifetime
- 2001-10-09 AU AU2002211219A patent/AU2002211219B2/en not_active Ceased
- 2001-10-09 PL PL01361675A patent/PL361675A1/xx not_active Application Discontinuation
- 2001-10-09 AT AT01979233T patent/ATE270280T1/de not_active IP Right Cessation
- 2001-10-09 AU AU1121902A patent/AU1121902A/xx active Pending
- 2001-10-09 TR TR2004/02046T patent/TR200402046T4/xx unknown
- 2001-10-09 MX MXPA03003217A patent/MXPA03003217A/es unknown
- 2001-10-09 HU HU0301351A patent/HUP0301351A3/hu unknown
- 2001-10-09 KR KR10-2003-7005203A patent/KR20030042014A/ko not_active Application Discontinuation
- 2001-10-09 DZ DZ013482A patent/DZ3482A1/fr active
-
2003
- 2003-02-28 ZA ZA200301720A patent/ZA200301720B/en unknown
- 2003-04-10 EC EC2003004551A patent/ECSP034551A/es unknown
- 2003-04-11 NO NO20031687A patent/NO20031687L/no unknown
- 2003-04-14 HR HR20030288A patent/HRP20030288B1/xx not_active IP Right Cessation
- 2003-12-31 HK HK03109504A patent/HK1058194A1/xx not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
AU1121902A (en) | 2002-04-29 |
KR20030042014A (ko) | 2003-05-27 |
AU2002211219B2 (en) | 2006-09-14 |
NO20031687D0 (no) | 2003-04-11 |
HUP0301351A2 (hu) | 2003-11-28 |
HRP20030288A2 (en) | 2004-02-29 |
NZ524232A (en) | 2005-01-28 |
EP1326851A1 (de) | 2003-07-16 |
DE60104141T2 (de) | 2005-06-30 |
DZ3482A1 (fr) | 2002-04-25 |
CN1469871A (zh) | 2004-01-21 |
HRP20030288B1 (en) | 2005-02-28 |
PL361675A1 (en) | 2004-10-04 |
NO20031687L (no) | 2003-05-08 |
HK1058194A1 (en) | 2004-05-07 |
IL154809A0 (en) | 2003-10-31 |
BR0114630A (pt) | 2003-07-01 |
MXPA03003217A (es) | 2003-06-06 |
SK4182003A3 (en) | 2004-01-08 |
TR200402046T4 (tr) | 2004-10-21 |
PT1326851E (pt) | 2004-11-30 |
CA2419388A1 (en) | 2002-04-25 |
ES2223926T3 (es) | 2005-03-01 |
ECSP034551A (es) | 2003-05-26 |
CZ20031029A3 (cs) | 2003-09-17 |
JP2004511552A (ja) | 2004-04-15 |
EA200300462A1 (ru) | 2003-08-28 |
EP1326851B1 (de) | 2004-06-30 |
DE60104141D1 (de) | 2004-08-05 |
EA006102B1 (ru) | 2005-08-25 |
ZA200301720B (en) | 2004-06-21 |
WO2002032888A1 (en) | 2002-04-25 |
HUP0301351A3 (en) | 2007-05-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE270280T1 (de) | Substituierte dipeptide zur förderung der sekretion von wachstumshormon | |
MY138258A (en) | Growth hormone secretagogues | |
EA200701293A1 (ru) | Терапевтическая композиция фактора роста кератиноцитов | |
DE602004020657D1 (de) | Neue verwendung von peptidverbindungen zur behandlung ovn zentralen neuropathischen schmerzen | |
ATE338767T1 (de) | Dipeptidische wachstumshormonsekretionsförderern | |
DE50309260D1 (de) | Verfahren zur herstellung von bicalutamid | |
DE60326128D1 (de) | Verwendung von mischungen von lipopeptiden zur bereitung von impfstoffen | |
ATE458490T1 (de) | Neues verfahren und neue zusammensetzung zur hemmung der angiogenese und des tumorwachstums unter verwendung von verbindungen auf basis einer sequenz in mmp-2 | |
ATE283366T1 (de) | Verfahren zur verwendung von viraler replicase | |
DE602004010530D1 (de) | Verfahren zur herstellung von phenyltetrazolderivaten | |
ATE235509T1 (de) | Peptide zur inhibition von hpv e7 proteinen | |
ATE319839T1 (de) | Verfahren zur verbesserung der transfektionseffizienz | |
DE602005007724D1 (de) | Verfahren zur halbsynthese von deserpidin | |
DE60003711D1 (de) | Verfahren zur herstellung von peptidzwischenprodukten | |
DE50312447D1 (de) | Verfahren zur herstellung von 4,6-dichlor-5-fluorpyrimidin | |
DE50210473D1 (de) | Phosphinat-peptidanaloga als inhibitoren der procollagen-c-proteinase (pcp) zur behandlung von fibrotischen erkrankungen | |
DK1572615T3 (da) | Fremgangsmåde til syntese af peptider indeholdende en 4-hydroxyprolin-substruktur | |
ATE453623T1 (de) | Synthese von dipeptidanaloga |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
UEP | Publication of translation of european patent specification |
Ref document number: 1326851 Country of ref document: EP |
|
REN | Ceased due to non-payment of the annual fee |